Brief: Cereno Scientific Granted FDA Fast Track For CS1 In PAH Treatment
26/08/2025 10:47
Aug 26 (Reuters) - Cereno Scientific AB CRNOSb.ST: GRANTED FDA FAST TRACK FOR CS1 IN PAH TREATMENT Source text: ID:nWkr91MCdT Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global